82 results
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
ANNOUNCES COMPLETION OF ACQUISITION OF CYMABAY
Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver
SC TO-T
EX-99
CBAY
Cymabay Therapeutics Inc
23 Feb 24
Third party tender offer statement
6:09am
USA), where she was a member of the faculty for more than 30 years and served as the Norman Davidson Leadership Chair of the division from 2009 … more than 20 years of increasing company leadership and commitment to transforming care delivery for patients with
Schedule A-4
Name, Country
8-K
EX-99.1
tzkhcm0pv
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
PX14A6G
tc204t7svuycjltppz2h
11 Apr 22
Letter to shareholders
6:01am
8-K
EX-99.1
6wnvmqld7u19eq o6
29 Apr 21
Gilead Sciences Announces First Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
ggyqoxbm2jbvfdt
4 Feb 21
Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:05pm
SC TO-T
EX-99
7tgx74agpmnjhayf e85
24 Sep 20
Third party tender offer statement
8:00am
SC TO-C
EX-99.1
u9tq3ki1efhynkm
17 Sep 20
Information about tender offer
4:53pm
SC TO-C
EX-99.3
4m2krx is5eb
14 Sep 20
Information about tender offer
5:28pm
SC TO-C
EX-99.2
s5i3wc8rbxdrhlxtsl
14 Sep 20
Information about tender offer
5:28pm
8-K
EX-99.1
uh2aqgnba4f2flv8
30 Jul 20
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
6:57pm